Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Ongoing research is also exploring whether similar effects extend to newer agents in this drug class and to broader AFib populations
The higher success rate reflects several factors: smaller, faster trials, more direct FDA engagement, willingness to use surrogate endpoints, and patient communities that are actively supportive of clinical participation
Integrating B12 with Conventional Pain Management Using B12 with usual pain treatments can help more
10.5185/amLett.2011.4256 11 Ctrdmdp (2011)
US$ 20.23
US$ 20.80
US$ 23.05
US$ 24.93
US$ 27.19
US$ 21.05
US$ 26.06
US$ 23.73
